GALT vs GILD: Which Stock is Better?

Side-by-side comparison of Galectin Therapeutics Inc and Gilead Sciences Inc in 2026

Comparison Updated:

GALT

Galectin Therapeutics Inc

GILD

Gilead Sciences Inc

$131.27

Key Metrics Comparison

MetricGALTGILDWinner
Market Cap$142.41M$160.15BGILD
P/E RatioN/A17.55GILD
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze GALT

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is GALT or GILD a better investment?

Comparing GALT and GILD: Galectin Therapeutics Inc has a market cap of $142.41M while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between GALT and GILD?

GALT (Galectin Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: GALT or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: GALT or GILD?

Both GALT and GILD show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: GALT or GILD?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: GALT or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $142.41M for GALT.

Should I buy GALT or GILD in 2026?

Both GALT and GILD have investment merit. GALT trades at $N/A while GILD trades at $131.27. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between GALT and GILD stock?

Key differences: Market Cap ($142.41M vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy GALT or GILD in 2026?

The choice between GALT and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between GALT and GILD?

GALT (Galectin Therapeutics Inc) has a market cap of $142.41M, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.

Popular Stock Comparisons